Compare GRANULES INDIA with Biocon - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GRANULES INDIA vs BIOCON - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    GRANULES INDIA BIOCON GRANULES INDIA/
BIOCON
 
P/E (TTM) x 15.7 46.5 33.9% View Chart
P/BV x 3.5 5.8 60.2% View Chart
Dividend Yield % 0.5 0.0 -  

Financials

 GRANULES INDIA   BIOCON
EQUITY SHARE DATA
    GRANULES INDIA
Mar-21
BIOCON
Mar-21
GRANULES INDIA/
BIOCON
5-Yr Chart
Click to enlarge
High Rs438488 89.8%   
Low Rs138275 50.3%   
Sales per share (Unadj.) Rs130.759.2 220.8%  
Earnings per share (Unadj.) Rs22.27.7 287.7%  
Cash flow per share (Unadj.) Rs28.313.7 207.0%  
Dividends per share (Unadj.) Rs1.500-  
Avg Dividend yield %0.50-  
Book value per share (Unadj.) Rs86.862.3 139.5%  
Shares outstanding (eoy) m247.671,200.00 20.6%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x2.26.4 34.2%   
Avg P/E ratio x13.049.4 26.3%  
P/CF ratio (eoy) x10.227.9 36.5%  
Price / Book Value ratio x3.36.1 54.2%  
Dividend payout %6.80-   
Avg Mkt Cap Rs m71,337457,350 15.6%   
No. of employees `000NANA-   
Total wages/salary Rs m3,24317,410 18.6%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m32,37571,058 45.6%  
Other income Rs m2696,052 4.4%   
Total revenues Rs m32,64477,110 42.3%   
Gross profit Rs m8,55213,145 65.1%  
Depreciation Rs m1,5157,151 21.2%   
Interest Rs m263577 45.6%   
Profit before tax Rs m7,04411,469 61.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,5492,215 69.9%   
Profit after tax Rs m5,4959,254 59.4%  
Gross profit margin %26.418.5 142.8%  
Effective tax rate %22.019.3 113.9%   
Net profit margin %17.013.0 130.3%  
BALANCE SHEET DATA
Current assets Rs m19,97076,004 26.3%   
Current liabilities Rs m11,73142,101 27.9%   
Net working cap to sales %25.447.7 53.3%  
Current ratio x1.71.8 94.3%  
Inventory Days Days16137 11.9%  
Debtors Days Days86363 1,379.7%  
Net fixed assets Rs m17,157106,142 16.2%   
Share capital Rs m2486,000 4.1%   
"Free" reserves Rs m21,26268,728 30.9%   
Net worth Rs m21,51074,728 28.8%   
Long term debt Rs m3,41129,616 11.5%   
Total assets Rs m37,127182,146 20.4%  
Interest coverage x27.820.9 133.2%   
Debt to equity ratio x0.20.4 40.0%  
Sales to assets ratio x0.90.4 223.5%   
Return on assets %15.55.4 287.3%  
Return on equity %25.512.4 206.3%  
Return on capital %29.311.5 254.0%  
Exports to sales %81.90-   
Imports to sales %26.87.2 375.2%   
Exports (fob) Rs m26,528NA-   
Imports (cif) Rs m8,6915,084 170.9%   
Fx inflow Rs m26,52811,791 225.0%   
Fx outflow Rs m8,6915,084 170.9%   
Net fx Rs m17,8376,707 265.9%   
CASH FLOW
From Operations Rs m4,32511,597 37.3%  
From Investments Rs m-2,771-36,247 7.6%  
From Financial Activity Rs m-2,99325,640 -11.7%  
Net Cashflow Rs m-1,441723 -199.3%  

Share Holding

Indian Promoters % 41.7 39.7 104.9%  
Foreign collaborators % 0.4 20.9 1.7%  
Indian inst/Mut Fund % 24.0 23.2 103.3%  
FIIs % 0.0 15.7 -  
ADR/GDR % 0.0 0.0 -  
Free float % 58.0 39.4 147.3%  
Shareholders   239,520 363,447 65.9%  
Pledged promoter(s) holding % 7.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare GRANULES INDIA With:   ZIM LABORATORIES  TORRENT PHARMA  PANACEA BIOTECH  AMRUTANJAN HEALTHCARE  MARKSANS PHARMA.  



Today's Market

5 Reasons Why Sensex Slumped 949 Points Today(Closing)

Indian share markets witnessed huge selling pressure today and ended deep in the red.

Related Views on News

BIOCON Announces Quarterly Results (2QFY22); Net Profit Up 4.9% (Quarterly Result Update)

Oct 26, 2021 | Updated on Oct 26, 2021

For the quarter ended September 2021, BIOCON has posted a net profit of Rs 2 bn (up 4.9% YoY). Sales on the other hand came in at Rs 18 bn (up 5.2% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

GRANULES INDIA 2020-21 Annual Report Analysis (Annual Result Update)

Oct 20, 2021 | Updated on Oct 20, 2021

Here's an analysis of the annual report of GRANULES INDIA for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of GRANULES INDIA. Also includes updates on the valuation of GRANULES INDIA.

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

More Views on News

Most Popular

Infosys vs TCS: Which is Better?(Views On News)

Nov 26, 2021

In the post pandemic era, the top two IT companies in India are fighting to capture the growing demand for IT.

This Multibagger Stock Zooms 20% After Dolly Khanna Buys Stake(Views On News)

Nov 24, 2021

Shares of this edible oil company zoomed over 50% in three days after ace investor bought around 1% stake.

6 Popular Stocks that Turned into Penny Stocks(Views On News)

Nov 27, 2021

A look at popular stocks that crashed big time and never recovered, i.e. which went from 'Multibaggers to Multibeggers'.

India's Top 5 Monopoly Stocks to Watch Out for(Views On News)

Nov 30, 2021

These 5 companies dominate their sectors with a huge piece of the pie.

5 Indian Companies Embracing Blockchain Technology(Views On News)

Nov 23, 2021

Blockchain adoption in India was slow in the past. Now, the technology is being well received.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

GRANULES INDIA SHARE PRICE


Dec 6, 2021 (Close)

TRACK GRANULES INDIA

  • Track your investment in GRANULES INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON GRANULES INDIA

GRANULES INDIA 5-YR ANALYSIS

COMPARE GRANULES INDIA WITH

MARKET STATS